Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Artificial Pancreas Pipeline Market Report Overview

The artificial pancreas helps people with diabetes, primarily type 1, to automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.

The artificial pancreas pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The US

·       Europe

·       China

·       Japan

·       South Korea

Key Regulatory Paths ·       PMA

·       CE

·       510(k)

·       NMPA

·       Shonin

Leading Companies ·       Admetsys Corp

·       Advanced Biosensors-Ohio LLC

·       AiTA Bio Inc

·       Beta-O2 Technologies Ltd

·       Bigfoot Biomedical Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Artificial Pancreas Pipeline Market Segmentation by Territories

A few of the key territories with the artificial pancreas pipeline market are the US, Europe, China, Japan, and South Korea. As of September 2024, the US accounted for the highest number of pipeline products.

Artificial Pancreas Pipeline Market Analysis by Territories, 2024 (%)

Artificial Pancreas Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Artificial Pancreas Pipeline Market

Download a Free Report Sample

Artificial Pancreas Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the artificial pancreas pipeline products market are PMA, CE, 510(k), NMPA, and Shonin. As of September 2024, PMA was the most followed pathway for pipeline products in the artificial pancreas market.

Artificial Pancreas Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Artificial Pancreas Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Artificial Pancreas Pipeline Market

Download a Free Report Sample

Artificial Pancreas Pipeline Market – Competitive Landscape

A few of the key companies associated with the artificial pancreas pipeline market are Admetsys Corp, Advanced Biosensors-Ohio LLC, AiTA Bio Inc, Beta-O2 Technologies Ltd, and Bigfoot Biomedical Inc., among others.

Beta-O2 Technologies Ltd: Headquartered in Rosh HaAyin, Israel, it is a biomedical company that develops proprietary implantable bio-artificial pancreas for the treatment of type 1 diabetes. The company’s bio-artificial pancreas is an implantable device that allows for immune isolation of the implanted cells, eliminating the need for frequent insulin injections, glucose measurements, and immunosuppressive therapy. Beta-O2 preclinically tests the bio-artificial adrenal as a treatment for stress disorders.

Bigfoot Biomedical Inc.: It is a medical device company that develops technologies to reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. It leverages data, connectivity, automation, and machine learning to automatically and continuously optimize insulin delivery for people with insulin-requiring diabetes and maximize the leverage of healthcare providers. Bigfoot Biomedical provides automated infusion pumps and connected insulin pen options for consumers to meet the needs of a diverse population with insulin-requiring diabetes.

Artificial Pancreas Pipeline Market Analysis by Companies, 2024

Artificial Pancreas Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Artificial Pancreas Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Artificial Pancreas Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Japan
  • South Korea

Artificial Pancreas Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • 510(k)
  • NMPA
  • Shonin

Scope

This report provides:

  • Extensive coverage of the artificial pancreas under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of artificial pancreas and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of artificial pancreas under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Admetsys Corp
Advanced Biosensors-Ohio LLC
AiTA Bio Inc
Beta Bionics Inc
Beta-O2 Technologies Ltd
Bigfoot Biomedical Inc
BioTex Inc
Captix Biomedical Pty Ltd
Cerco Medical LLC
Children's Hospital of Philadelphia
Converge Biotech, Inc.
Covalor Medical, LLC
De Montfort University
Debiotech SA
Defymed SAS
Diabeloop SA
EOFlow Co Ltd
Giner Inc
Haimai Medical Technology Co Ltd
Harvard John A Paulson School of Engineering and Applied Sciences
Healios Inc
Humacyte Inc
Ideal Medical Technologies Inc
Imperial College London
Indian Institute of Science
Joslin Diabetes Center
Kailian Medical Technology Co Ltd
Kencak LLC
Massachusetts Institute of Technology
McGill University
Medtronic Inc
Medtronic MiniMed Inc
MicroTech Medical Inc
Miromatrix Medical Inc
Modular Medical Inc
Novoculi
Pacific Diabetes Technologies Inc
Pancreum, LLC
PharmaCyte Biotech Inc
Polytechnic University of Valencia
Rensselaer Polytechnic Institute
Senseonics Holdings Inc
SFC Fluidics LLC
Shenzhen Huayuan Regenerative Medicine Co Ltd
Stanford University
TecMed Inc
Thermalin Inc
TypeZero Technologies LLC
U-Needle BV
Universidad Autonoma de Madrid
University of California San Francisco
University of California Santa Barbara
University of Cambridge
University of Florida
University of Minnesota
University of Newcastle
University of Queensland
University of Virginia
ViCentra BV
WaveForm Technologies, Inc
Xeris Biopharma Holdings Inc
Yale University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 12

2 Introduction 13

2.1 Artificial Pancreas Overview 13

3 Products under Development 14

3.1 Artificial Pancreas – Pipeline Products by Stage of Development 14

3.2 Artificial Pancreas – Pipeline Products by Territory 15

3.3 Artificial Pancreas – Pipeline Products by Regulatory Path 16

3.4 Artificial Pancreas – Pipeline Products by Estimated Approval Date 17

3.5 Artificial Pancreas – Ongoing Clinical Trials 18

4 Artificial Pancreas – Pipeline Products under Development by Companies 19

4.1 Artificial Pancreas Companies – Pipeline Products by Stage of Development 19

4.2 Artificial Pancreas – Pipeline Products by Stage of Development 22

5 Artificial Pancreas Companies and Product Overview 24

5.1 Admetsys Corp Company Overview 24

5.1.1 Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview 24

5.2 Advanced Biosensors-Ohio LLC Company Overview 26

5.2.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 26

5.3 AiTA Bio Inc Company Overview 27

5.3.1 AiTA Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.4 Beta Bionics Inc Company Overview 28

5.4.1 Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 Beta-O2 Technologies Ltd Company Overview 30

5.5.1 Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.6 Bigfoot Biomedical Inc Company Overview 33

5.6.1 Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.7 BioTex Inc Company Overview 34

5.7.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.8 Captix Biomedical Pty Ltd Company Overview 35

5.8.1 Captix Biomedical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 35

5.9 Cerco Medical LLC Company Overview 36

5.9.1 Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 36

5.10 Children’s Hospital of Philadelphia Company Overview 37

5.10.1 Children’s Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview 37

5.11 Converge Biotech, Inc. Company Overview 38

5.11.1 Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38

5.12 Covalor Medical, LLC Company Overview 39

5.12.1 Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 39

5.13 De Montfort University Company Overview 40

5.13.1 De Montfort University Pipeline Products & Ongoing Clinical Trials Overview 40

5.14 Debiotech SA Company Overview 41

5.14.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 41

5.15 Defymed SAS Company Overview 42

5.15.1 Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview 42

5.16 Diabeloop SA Company Overview 43

5.16.1 Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview 43

5.17 EOFlow Co Ltd Company Overview 45

5.17.1 EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

5.18 Giner Inc Company Overview 46

5.18.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.19 Haimai Medical Technology Co Ltd Company Overview 47

5.19.1 Haimai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.20 Harvard John A Paulson School of Engineering and Applied Sciences Company Overview 48

5.20.1 Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview 48

5.21 Healios Inc Company Overview 49

5.21.1 Healios Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.22 Humacyte Inc Company Overview 50

5.22.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.23 Ideal Medical Technologies Inc Company Overview 51

5.23.1 Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.24 Imperial College London Company Overview 54

5.24.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 54

5.25 Indian Institute of Science Company Overview 55

5.25.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 55

5.26 Joslin Diabetes Center Company Overview 56

5.26.1 Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview 56

5.27 Kailian Medical Technology Co Ltd Company Overview 57

5.27.1 Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

5.28 Kencak LLC Company Overview 59

5.28.1 Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview 59

5.29 Massachusetts Institute of Technology Company Overview 60

5.29.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 60

5.30 McGill University Company Overview 61

5.30.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 61

5.31 Medtronic Inc Company Overview 62

5.31.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.32 Medtronic MiniMed Inc Company Overview 64

5.32.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.33 MicroTech Medical Inc Company Overview 65

5.33.1 MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.34 Miromatrix Medical Inc Company Overview 67

5.34.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.35 Modular Medical Inc Company Overview 68

5.35.1 Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.36 Novoculi Company Overview 69

5.36.1 Novoculi Pipeline Products & Ongoing Clinical Trials Overview 69

5.37 Pacific Diabetes Technologies Inc Company Overview 70

5.37.1 Pacific Diabetes Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.38 Pancreum, LLC Company Overview 73

5.38.1 Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview 73

5.39 PharmaCyte Biotech Inc Company Overview 74

5.39.1 PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.40 Polytechnic University of Valencia Company Overview 75

5.40.1 Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 75

5.41 Rensselaer Polytechnic Institute Company Overview 76

5.41.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 76

5.42 Senseonics Holdings Inc Company Overview 77

5.42.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.43 SFC Fluidics LLC Company Overview 78

5.43.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 78

5.44 Shenzhen Huayuan Regenerative Medicine Co Ltd Company Overview 79

5.44.1 Shenzhen Huayuan Regenerative Medicine Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 79

5.45 Stanford University Company Overview 80

5.45.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 80

5.46 TecMed Inc Company Overview 81

5.46.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 81

5.47 Thermalin Inc Company Overview 82

5.47.1 Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.48 TypeZero Technologies LLC Company Overview 84

5.48.1 TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 84

5.49 U-Needle BV Company Overview 87

5.49.1 U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview 87

5.50 Universidad Autonoma de Madrid Company Overview 88

5.50.1 Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview 88

5.51 University of California San Francisco Company Overview 89

5.51.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 89

5.52 University of California Santa Barbara Company Overview 90

5.52.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 90

5.53 University of Cambridge Company Overview 92

5.53.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 92

5.54 University of Florida Company Overview 95

5.54.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 95

5.55 University of Minnesota Company Overview 96

5.55.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 96

5.56 University of Newcastle Company Overview 97

5.56.1 University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 97

5.57 University of Queensland Company Overview 98

5.57.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 98

5.58 University of Virginia Company Overview 99

5.58.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 99

5.59 ViCentra BV Company Overview 100

5.59.1 ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 100

5.60 WaveForm Technologies, Inc Company Overview 101

5.60.1 WaveForm Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.61 Xeris Biopharma Holdings Inc Company Overview 102

5.61.1 Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 102

5.62 Yale University Company Overview 103

5.62.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 103

6 Artificial Pancreas – Recent Developments 104

6.1 Sep 04, 2024: Beta Bionics Announces Partnership With Abbott to Integrate the iLet Bionic Pancreas With the FreeStyle Libre 3 Plus iCGM 104

6.2 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference 104

6.3 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference 104

6.4 Aug 15, 2024: Beta Bionics Celebrates Milestone: 10,000th iLet Patient 105

6.5 Jun 25, 2024: Humacyte Presents Positive Preclinical Data For Its BioVascular Pancreas (BVP) Program 105

6.6 Jun 13, 2024: Medtronic Confirms Global Layoffs 106

6.7 Apr 03, 2024: Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024 106

6.8 Apr 02, 2024: NHS Rolls Out Artificial Pancreas in World First Move 106

6.9 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 108

6.10 Feb 13, 2024: Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference 108

6.11 Nov 14, 2023: Tandem Diabetes Care Receives Additional 510(K) Clearance For t:slim X2 Control-IQ System – Pediatrics 108

6.12 Nov 14, 2023: Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts National Commercial Formularies 109

6.13 Oct 12, 2023: Mylife Loop Improves Health of Pregnant Women With Type 1 Diabetes and Their Babies 109

6.14 Oct 04, 2023: Boston University Names Melissa L. Gilliam 11th President 110

6.15 Sep 25, 2023: Medtronic to Present New Data That Adds to the Proven Success of Minimedtm 780G System at the European Association for the Study of Diabetes (EASD) 59th Annual Meeting 111

7 Appendix 113

7.1 Methodology 113

7.2 About GlobalData 116

7.3 Contact Us 116

7.4 Disclaimer 116

Table

Artificial Pancreas – Pipeline Products by Stage of Development 13

Artificial Pancreas – Pipeline Products by Territory 14

Artificial Pancreas – Pipeline Products by Regulatory Path 15

Artificial Pancreas – Pipeline Products by Estimated Approval Date 16

Artificial Pancreas – Ongoing Clinical Trials 17

Artificial Pancreas Companies – Pipeline Products by Stage of Development 18

Artificial Pancreas – Pipeline Products by Stage of Development 21

Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview 23

Smart Pancreas – Product Status 23

Smart Pancreas – Product Description 24

Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 25

Artificial Pancreas – Product Status 25

Artificial Pancreas – Product Description 25

AiTA Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Next-Generation Artificial Pancreas – Product Status 26

Next-Generation Artificial Pancreas – Product Description 26

Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Gen 2 GlucoSTAT – Product Status 27

Gen 2 GlucoSTAT – Product Description 27

Gen 4 iLet System – Product Status 28

Gen 4 iLet System – Product Description 28

Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

ßAir Bio-artificial Pancreas – Product Status 29

ßAir Bio-artificial Pancreas – Product Description 29

Beta-O2 Technologies Ltd – Ongoing Clinical Trials Overview 30

ßAir Bio-artificial Pancreas – An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas Beta-air in Patients with Type 1 Diabetes Mellitus 31

Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Bigfoot Autonomy – Product Status 32

Bigfoot Autonomy – Product Description 32

BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Artificial Pancreas – Product Status 33

Artificial Pancreas – Product Description 33

Captix Biomedical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

IMITA Device – Product Status 34

IMITA Device – Product Description 34

Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Bioartificial Pancreas – Product Status 35

Bioartificial Pancreas – Product Description 35

Children’s Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview 36

Bihormonal Bionic Pancreas – Product Status 36

Bihormonal Bionic Pancreas – Product Description 36

Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

Bioartificial Pancreas System – Product Status 37

Bioartificial Pancreas System – Product Description 37

Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 38

Artificial Pancreas – Product Status 38

Artificial Pancreas – Product Description 38

De Montfort University Pipeline Products & Ongoing Clinical Trials Overview 39

InSmart Artificial Pancreas – Product Status 39

InSmart Artificial Pancreas – Product Description 39

Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 40

Next Generation Artificial Pancreas – Product Status 40

Next Generation Artificial Pancreas – Product Description 40

Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview 41

MAILPAN – Product Status 41

MAILPAN – Product Description 41

Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview 42

Automated Insulin Delivery System – Product Status 42

Automated Insulin Delivery System – Product Description 42

DBLG1 – Pediatric Version – Product Status 43

DBLG1 – Pediatric Version – Product Description 43

EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

EOPatchX – Product Status 44

EOPatchX – Product Description 44

Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 45

BAPIOS System – Product Status 45

BAPIOS System – Product Description 45

Haimai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Biological Pancreas – Product Status 46

Biological Pancreas – Product Description 46

Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview 47

Pregnancy-Specific Artificial Pancreas – Product Status 47

Pregnancy-Specific Artificial Pancreas – Product Description 47

Healios Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Bioengineered Pancreas – Product Status 48

Bioengineered Pancreas – Product Description 48

Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 49

BioVascular Pancreas – Product Status 49

BioVascular Pancreas – Product Description 49

Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Fusion System – Product Status 50

Fusion System – Product Description 50

Ideal Medical Technologies Inc – Ongoing Clinical Trials Overview 51

Fusion System – Demonstration of an Artificial Intelligence Based Closed Loop Glucose Control System as a Therapeutic Modality in Type 1 and Type 2 Diabetic Patients 52

Fusion System – Prospective Randomized Controlled Trial For Use of the FUSION Artificial Pancreas System as a Therapy for COVID-19 52

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 53

Bio-inspired Artificial Pancreas – Product Status 53

Bio-inspired Artificial Pancreas – Product Description 53

Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 54

Artificial Pancreas System – Product Status 54

Artificial Pancreas System – Product Description 54

Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview 55

Closed-Loop Glucagon Delivery System – Product Status 55

Closed-Loop Glucagon Delivery System – Product Description 55

Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

Artificial Pancreas System – Product Status 56

Artificial Pancreas System – Product Description 56

Semi-Closed-Loop Blood Glucose Management Device – Product Status 57

Semi-Closed-Loop Blood Glucose Management Device – Product Description 57

Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview 58

BioArtificial Pancreas – Product Status 58

BioArtificial Pancreas – Product Description 58

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 59

Artificial Pancreas – Product Status 59

Artificial Pancreas – Product Description 59

McGill University Pipeline Products & Ongoing Clinical Trials Overview 60

Artificial Pancreas – Type 1 Diabetes – Product Status 60

Artificial Pancreas – Type 1 Diabetes – Product Description 60

Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Implantable Artificial Pancreas Device – Product Status 61

Implantable Artificial Pancreas Device – Product Description 61

Third-Generation Artificial Pancreas System – Product Status 62

Third-Generation Artificial Pancreas System – Product Description 62

Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Minimed 890G – Product Status 63

Minimed 890G – Product Description 63

MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 64

PanCares – Artificial Pancreas – Product Status 64

PanCares – Artificial Pancreas – Product Description 64

PanCares – Children And Adolescents – Product Status 65

PanCares – Children And Adolescents – Product Description 65

Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Miro Pancreas – Product Status 66

Miro Pancreas – Product Description 66

Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 67

MODD2 – Product Status 67

MODD2 – Product Description 67

Novoculi Pipeline Products & Ongoing Clinical Trials Overview 68

Closed-Loop System – Product Status 68

Closed-Loop System – Product Description 68

Pacific Diabetes Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 69

SynerG – Product Status 69

SynerG – Product Description 69

Pacific Diabetes Technologies Inc – Ongoing Clinical Trials Overview 70

SynerG – A 48hr Study to Test Feasibility of the Pacific Diabetes Technologies Continuous Glucose Monitor Infusion Set (CGMIS) Sensing Interstitial Glucose Continuously in the Immediate Vicinity of SQ Insulin Delivery in Adults With T1 Diabetes 71

SynerG – A Seven Day Study of the SynerG Insulin-Delivery and Glucose Sensor System in Persons with Type 1 Diabetes 71

SynerG – Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes 71

Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview 72

Genesis Artificial Pancreas – Product Status 72

Genesis Artificial Pancreas – Product Description 72

PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 73

Bio-Artificial Pancreas – Product Status 73

Bio-Artificial Pancreas – Product Description 73

Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 74

ClosedLoop 4Meal – Product Status 74

ClosedLoop 4Meal – Product Description 74

Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 75

Closed-Loop Artificial Pancreas System – Product Status 75

Closed-Loop Artificial Pancreas System – Product Description 75

Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 76

Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Product Status 76

Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Product Description 76

SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 77

Pod Automated Insulin Delivery Device – Product Status 77

Pod Automated Insulin Delivery Device – Product Description 77

Shenzhen Huayuan Regenerative Medicine Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

Bioartificial Pancreas – Type I Diabetes – Product Status 78

Bioartificial Pancreas – Type I Diabetes – Product Description 78

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 79

Artificial Pancreas Device – Product Status 79

Artificial Pancreas Device – Product Description 79

TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 80

Artificial Pancreas – Product Status 80

Artificial Pancreas – Product Description 80

Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview 81

Stabilized and Ultra-Rapid Insulin Pump – Product Status 81

Stabilized and Ultra-Rapid Insulin Pump – Product Description 81

StampPump – Product Status 82

StampPump – Product Description 82

TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 83

inControl – Product Status 83

inControl – Product Description 83

TypeZero Technologies LLC – Ongoing Clinical Trials Overview 84

inControl – Feasibility of Automated Insulin Delivery with an Interoperable Algorithm Using an Alternative Insulin Pump 85

U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview 86

Microneedle Artificial Pancreas – Product Status 86

Microneedle Artificial Pancreas – Product Description 86

Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview 87

Predictive Rule-Based Algorithm – Product Status 87

Predictive Rule-Based Algorithm – Product Description 87

University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 88

Implantable Bioartificial Pancreas – Product Status 88

Implantable Bioartificial Pancreas – Product Description 88

University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 89

Closed-Loop Artificial Pancreas – Product Status 89

Closed-Loop Artificial Pancreas – Product Description 89

Pediatric Artificial Pancreas – Product Status 90

Pediatric Artificial Pancreas – Product Description 90

University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 91

Artificial Pancreas – Type 2 Diabetes – Product Status 91

Artificial Pancreas – Type 2 Diabetes – Product Description 91

Florence D2A System – Product Status 92

Florence D2A System – Product Description 92

FlorenceM – Product Status 92

FlorenceM – Product Description 93

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 94

Bioartificial Pancreas – Type 1 Diabetes – Product Status 94

Bioartificial Pancreas – Type 1 Diabetes – Product Description 94

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 95

Implantable Microvalve Device – Product Status 95

Implantable Microvalve Device – Product Description 95

University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 96

Closed Glucose-Sensing Insulin-Delivery System – Product Status 96

Closed Glucose-Sensing Insulin-Delivery System – Product Description 96

University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 97

Bionic Artificial Pancreas – Product Status 97

Bionic Artificial Pancreas – Product Description 97

University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 98

Neural Net Artificial Pancreas – Product Status 98

Neural Net Artificial Pancreas – Product Description 98

ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 99

Kaleido Hybrid Closed Loop System – Product Status 99

Kaleido Hybrid Closed Loop System – Product Description 99

WaveForm Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 100

Closed Loop Insulin Delivery Solution – Product Status 100

Closed Loop Insulin Delivery Solution – Product Description 100

Xeris Biopharma Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 101

Bi-Hormonal Artificial Pancreas – Product Status 101

Bi-Hormonal Artificial Pancreas – Product Description 101

Yale University Pipeline Products & Ongoing Clinical Trials Overview 102

Automated Insulin Delivery System – Product Status 102

Automated Insulin Delivery System – Product Description 102

Glossary 114

Figures

Artificial Pancreas – Pipeline Products by Stage of Development 13

Artificial Pancreas – Pipeline Products by Territory 14

Artificial Pancreas – Pipeline Products by Regulatory Path 15

Artificial Pancreas – Pipeline Products by Estimated Approval Date 16

Artificial Pancreas – Ongoing Clinical Trials 17

Frequently asked questions

Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.